Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 3/2014

01-04-2014 | Letter to the Editor

Use of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysis

Authors: John Goudevenos, Ioannis Ntalas, Ioanna Xanthopoulou, Kallirroi Kalantzi, Athanasios Pipilis, Dimitrios Alexopoulos

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2014

Login to get access

Excerpt

To the Editor, …
Literature
1.
O’Gara PT, Kushner FG, Ascheim DD et al (2013) 2013 ACCF/AHA guidelines for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:e78–e140PubMedCrossRef
2.
Diego A, Pérez de Prado A, Cuellas C et al (2012) P2Y12 platelet reactivity after thrombolytic therapy for ST-segment elevation myocardial infarction. Thromb Res 130:e31–e36PubMedCrossRef
3.
Parodi G, Valenti R, Bellandi B (2013) Comparison of prasugrel and ticagrelor loading doses in STEMI patients: the rapid activity of platelet inhibitor drugs (RAPID) primary PCI Study. J Am Coll Cardiol 61:1601–1606PubMedCrossRef
4.
Alexopoulos D, Xanthopoulou I, Gkizas V et al (2012) Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv 5:797–804PubMedCrossRef
5.
Wallentin L, Becker RC, Budaj A, PLATO Investigators et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045–1057PubMedCrossRef
Metadata
Title
Use of ticagrelor in patients with ST-elevation myocardial infarction undergoing thrombolysis
Authors
John Goudevenos
Ioannis Ntalas
Ioanna Xanthopoulou
Kallirroi Kalantzi
Athanasios Pipilis
Dimitrios Alexopoulos
Publication date
01-04-2014
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2014
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-013-0972-2

Other articles of this Issue 3/2014

Journal of Thrombosis and Thrombolysis 3/2014 Go to the issue

OriginalPaper

Autoantibodies to phosphorylcholine and cardiovascular outcomes in patients with acute coronary syndromes in the ATLAS ACS-TIMI 46 trial

OriginalPaper

Pulmonary embolism in pregnancy

ReviewPaper

Antiplatelet therapy in prevention of cardio- and venous thromboembolic events

OriginalPaper

The ultrasound contrast imaging properties of lipid microbubbles loaded with urokinase in dog livers and their thrombolytic effects when combined with low-frequency ultrasound in vitro

Letter to the Editor

Modern antiplatelet management of coronary artery bypass patients: a role of platelet function testing in decision making

Report

Lemierre’s syndrome: the forgotten disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits